Baidu
map

BJC:新的测试将癌症复发消灭在萌芽状态!

2017-07-07 sunshine2015 来宝网

根据英国“癌症杂志”今日公布的研究,科学家们已经设计了一种简单的测试方法,对现有方法进行膀胱癌的早期准确预警。

根据英国“癌症杂志”今日公布的研究,科学家们已经设计了一种简单的测试方法,对现有方法进行膀胱癌的早期准确预警。

里昂大学医院的研究人员对348例膀胱癌患者的尿液进行了一项名为TERT的有缺陷的蛋白质的尿液检测,这可以预测80%以上的患者癌症将何时复发。称为细胞学检查的标准方法仅检测了34%的患者的复发率。

新的检测检测到膀胱癌尚未扩散到肌肉壁,比细胞学更早,可能有助于医生在症状出现之前及早开始治疗。

另一个好处是,新的检测将癌症与尿路感染区别开来。

里昂肿瘤研究所大学医院研究员Alain Ruffion教授说:“标准细胞学检查需要医生往下看显微镜来阅读结果,但TERT测试是由更简单,更准确的机器读取的并且可以直接使用,虽然TERT测试的成本略高于标准细胞学检查,但随着时间的推移可能会变得更便宜。

“测试对尿路感染没有反应的事实是非常有趣的,因为它表明它是强有力的,不太可能产生误导性的结果。”

该发现还表明,需要进一步的研究来了解更多关于TERT缺陷在膀胱癌中发挥的作用。

癌症研究英国资深科学信息经理Anna Perman表示:“这项有希望的研究表明,一种新的更准确的预警系统可以检测膀胱癌是否有可能复发。现在需要更大的试验来确定这些信息是否可以帮助更多人们通过在最早的阶段发现膀胱癌的复发,从而生存下去。”

原始出处:

Françoise Descotes, Norelyakin Kara, et al. Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine. British Journal of Cancer , (6 July 2017) | doi:10.1038/bjc.2017.210

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=220430, encodeId=8b2e2204302c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jul 09 23:09:37 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220427, encodeId=eaf922042e95, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jul 09 23:08:56 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425288, encodeId=e91b1425288dd, content=<a href='/topic/show?id=7eb6e134273' target=_blank style='color:#2F92EE;'>#癌症复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71342, encryptionId=7eb6e134273, topicName=癌症复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad3959854, createdName=lq0302, createdTime=Sun Jul 09 14:10:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220185, encodeId=50cf22018565, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sun Jul 09 07:14:28 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=219807, encodeId=4a3e21980ee7, content=这个观点独特, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Jul 08 07:48:11 CST 2017, time=2017-07-08, status=1, ipAttribution=)]
    2017-07-09 luominglian113

    学习了,谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=220430, encodeId=8b2e2204302c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jul 09 23:09:37 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220427, encodeId=eaf922042e95, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jul 09 23:08:56 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425288, encodeId=e91b1425288dd, content=<a href='/topic/show?id=7eb6e134273' target=_blank style='color:#2F92EE;'>#癌症复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71342, encryptionId=7eb6e134273, topicName=癌症复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad3959854, createdName=lq0302, createdTime=Sun Jul 09 14:10:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220185, encodeId=50cf22018565, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sun Jul 09 07:14:28 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=219807, encodeId=4a3e21980ee7, content=这个观点独特, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Jul 08 07:48:11 CST 2017, time=2017-07-08, status=1, ipAttribution=)]
    2017-07-09 luominglian113

    学习了,谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=220430, encodeId=8b2e2204302c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jul 09 23:09:37 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220427, encodeId=eaf922042e95, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jul 09 23:08:56 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425288, encodeId=e91b1425288dd, content=<a href='/topic/show?id=7eb6e134273' target=_blank style='color:#2F92EE;'>#癌症复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71342, encryptionId=7eb6e134273, topicName=癌症复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad3959854, createdName=lq0302, createdTime=Sun Jul 09 14:10:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220185, encodeId=50cf22018565, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sun Jul 09 07:14:28 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=219807, encodeId=4a3e21980ee7, content=这个观点独特, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Jul 08 07:48:11 CST 2017, time=2017-07-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=220430, encodeId=8b2e2204302c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jul 09 23:09:37 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220427, encodeId=eaf922042e95, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jul 09 23:08:56 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425288, encodeId=e91b1425288dd, content=<a href='/topic/show?id=7eb6e134273' target=_blank style='color:#2F92EE;'>#癌症复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71342, encryptionId=7eb6e134273, topicName=癌症复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad3959854, createdName=lq0302, createdTime=Sun Jul 09 14:10:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220185, encodeId=50cf22018565, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sun Jul 09 07:14:28 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=219807, encodeId=4a3e21980ee7, content=这个观点独特, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Jul 08 07:48:11 CST 2017, time=2017-07-08, status=1, ipAttribution=)]
    2017-07-09 龙胆草

    学习谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=220430, encodeId=8b2e2204302c, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jul 09 23:09:37 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220427, encodeId=eaf922042e95, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jul 09 23:08:56 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425288, encodeId=e91b1425288dd, content=<a href='/topic/show?id=7eb6e134273' target=_blank style='color:#2F92EE;'>#癌症复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71342, encryptionId=7eb6e134273, topicName=癌症复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad3959854, createdName=lq0302, createdTime=Sun Jul 09 14:10:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220185, encodeId=50cf22018565, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sun Jul 09 07:14:28 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=219807, encodeId=4a3e21980ee7, content=这个观点独特, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Jul 08 07:48:11 CST 2017, time=2017-07-08, status=1, ipAttribution=)]
    2017-07-08 飛歌

    这个观点独特

    0

相关资讯

JAMA Oncol:HER2阳性乳腺癌易致免疫缺陷 促进癌症复发

HER2阳性乳腺癌患者在接受治疗后出现复发可能是由于身体免疫系统存在一种癌症造成的特异性缺陷所导致,而根据宾夕法尼亚大学Perelman医学院研究人员的一项最新研究成果,靶向HER2的疫苗能够对这种免疫系统缺陷进行补救。相关研究结果发表在国际学术期刊JAMA Oncology上。 研究结果显示乳腺癌复发病人体内的T细胞与未复发病人体内的T细胞相比,其对HER2受体蛋白的应答要弱得多,这表明在未来

PNAS:增进免疫功能药物可抑癌复发

     每年,约有700,000名患者接受原发性肿瘤切除术,其中将近一半都会某个时间点出现复发,并且很多这类患者最终将因为他们的疾病而死亡。传统观点认为,肿瘤复发是由于它们获得了新的基因突变使得它们更具有侵袭性,并且使得药物不容易穿过细胞,从而对抗肿瘤治疗形成耐受。然而,宾夕法尼亚大学佩雷尔曼(Perelman)医学院的研究人员在动物模型上证实,复发肿瘤侵袭性的增强或许是由于机体免疫系统

PNAS:癌症复发的关键酶:ADAR1

  慢性粒细胞性白血病CML是一种血液和骨髓癌,其患病率正在逐年增加。日前,加州大学圣迭戈分校医学院的研究人员发现,在促进干细胞恶意增殖和CML发展的重编程过程中存在着一种关键的酶。这一发现提前发表在十二月二十四日美国国家科学院院刊PNAS杂志的网站上。   美国目前有七万人患有CML,预计到2050年这一数字将稳定增长到约181000人。CML是BCR-ABL基因突变引起的,但科学家尚还不清楚

Psychooncology:你知道担忧癌症复发与自身健康存在怎样的相关性吗?

癌症患者和幸存者都会时常担忧癌症复发。那么,是什么驱动患者产生这种担忧呢?患者对于癌症复发的担忧是否会影响其自身健康呢?近期,来自英国圣安德鲁斯大学医学院Gerald Humphris团队进行的荟萃分析发现,手术后再行化疗,与患者对癌症复发的担忧之间存在较弱的相关性。

Nat Nanotechnol:开发出新的抗癌纳米颗粒,有望长期阻止癌症复发

在一项新的研究中,来自美国梅约诊所等研究机构的研究人员开发出一种新的旨在让乳腺瘤萎缩同时阻止其复发的抗癌纳米颗粒。接受这种纳米颗粒注射的小鼠的肿瘤大小下降了70~80%。最令人关注的是,接受这种纳米颗粒治疗的小鼠抵抗未来的肿瘤复发,即便在治疗一个月后接触到癌细胞,也是如此。相关研究结果于2017年5月1日在线发表在Nature Nanotechn

Baidu
map
Baidu
map
Baidu
map